1. Kyoto University Research Information Repository
  2. 060　医学研究科・医学部・医学部附属病院
  3. 泌尿器科紀要
  4. Vol.27 No.11
ダウンロード数: 252

    このアイテムの引用には次の識別子を使用してください: http://hdl.handle.net/2433/123227
このアイテムのファイル:
ファイル 記述 サイズフォーマット 
27_1473.pdf365.1 kBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド値言語
dc.contributor.author香村, 衡一ja
dc.contributor.author安田, 耕作ja
dc.contributor.author中山, 朝行ja
dc.contributor.author浜, 年樹ja
dc.contributor.author山城, 豊ja
dc.contributor.author北村, 温ja
dc.contributor.author島崎, 淳ja
dc.contributor.author服部, 孝道ja
dc.contributor.author村上, 信乃ja
dc.contributor.alternativeKamura, Koichien
dc.contributor.alternativeYasuda, Kosakuen
dc.contributor.alternativeNakayama, Tomoyukien
dc.contributor.alternativeHama, Toshikien
dc.contributor.alternativeYamashiro, Yutakaen
dc.contributor.alternativeKitamura, Yutakaen
dc.contributor.alternativeShimazaki, Junen
dc.contributor.alternativeHattori, Takamichien
dc.contributor.alternativeMurakami, Shinoen
dc.date.accessioned2010-07-23T06:52:38Z-
dc.date.available2010-07-23T06:52:38Z-
dc.date.issued1981-11-
dc.identifier.issn0018-1994-
dc.identifier.urihttp://hdl.handle.net/2433/123227-
dc.description.abstractThe clinical effect of Prazosin, an alpha blocking agent, was studied in 18 patients with neurogenic bladder dysfunction. The patients consisted of 11 supranuclear and 7 infranuclear type according to the neurological examinations. The daily doses of 0.5-4 mg of Prazosin was given for 1 week to 6 months. The result was as follows: excellent in 8, good in 3 and poor in 7 cases. The overall success rate was 61 % (5 cases in supranuclear type and 6 cases in infranuclear type). A few side effects were noted such as orthostatic hypotension, nausea, diarrhea and urinary frequency. Thus, Prazosin seems to be an effective drug for treatment of neurogenic bladder dysfunction.en
dc.format.mimetypeapplication/pdf-
dc.language.isojpn-
dc.publisher京都大学医学部泌尿器科学教室ja
dc.publisher.alternativeDepartment of Urology, Faculty of Medicine, Kyoto Univeersityen
dc.subject.ndc494.9-
dc.title神経因性膀胱に対するPrazosinの効果ja
dc.title.alternativePRAZOSIN IN NEUROGENIC BLADDER DYSFUNCTIONen
dc.typedepartmental bulletin paper-
dc.type.niitypeDepartmental Bulletin Paper-
dc.identifier.ncidAN00208315-
dc.identifier.jtitle泌尿器科紀要ja
dc.identifier.volume27-
dc.identifier.issue11-
dc.identifier.spage1473-
dc.identifier.epage1478-
dc.textversionpublisher-
dc.sortkey19-
dc.address千葉大学医学部泌尿器科学教室ja
dc.address千葉大学医学部神経内科学教室ja
dc.address旭中央病院泌尿器科ja
dc.address.alternativeThe Department of Urology, School of Medicine, Chiba Universityen
dc.address.alternativeThe Department of Neurology, School of Medicine, Chiba Universityen
dc.address.alternativeThe Department of Urology, Asahi General Hospitalen
dcterms.accessRightsopen access-
dc.identifier.pissn0018-1994-
dc.identifier.jtitle-alternativeActa urologica Japonicala
dc.identifier.jtitle-alternativeHinyokika Kiyoen
出現コレクション:Vol.27 No.11

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。